180416-55-1

N-[3-Chloro-4-(10,11-dihydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-10-ylcarbonyl)phenyl]biphenyl-2-carboxamide

Catalog No.	1894442
Name	N-[3-Chloro-4-(10,11-dihydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-10-ylcarbonyl)phenyl]biphenyl-2-carboxamide
CAS	180416-55-1
Formula	C32H24ClN3O2

Carbamic acid, [4-(azidomethyl)-2-(1-methylethoxy)phenyl]-,1,1-dimethylethyl ester

Cycloheptanone, 2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-7-hydroxy-,(2R,7R)-rel-

Cycloheptanone,[(4-chlorophenyl)[4-[(methylsulfonyl)oxy]phenyl]methylene]hydrazone

Carbamic acid, [4-[(hydroxyamino)carbonyl]phenyl]-,[6-[(dibutylamino)methyl]-2-naphthalenyl]methyl ester

Cycloheptene, 3-methoxy-7-methyl-1-(phenylsulfonyl)-, (3S,7S)-

Carbamic acid, [4-(1H-imidazo[4,5-b]pyridin-1-yl)butyl]-,1,1-dimethylethyl ester

Butanoic acid, 3-[[2-(acetylamino)-3-methoxy-3-oxopropyl]thio]-, methylester

Carbamic acid, [3-hydroxy-4,4-dimethyl-2-(2-naphthalenyl)pentyl]-

Benzenemethanol,2-azido-a-[3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-1-propynyl]-, acetate(ester)

Cyclohexanamine, 5-ethyl-1,3,3-trimethyl-, (1R,5S)-rel-

Piperazine,1-(4-acetyl-2-fluorophenyl)-4-[5-cyano-2-(4-morpholinyl)benzoyl]-

Butanoic acid, 2-methyl-, (methylthio)methyl ester

Butanoic acid, 3-[[(4-methylphenyl)sulfonyl]hydrazono]-,1,1-dimethylethyl ester

Benzeneethanamine, 4,5-dimethoxy-a-methyl-2-(methylthio)-,hydrochloride

[1,2,4]Triazolo[1,5-a]pyrimidine, 5,7-dimethyl-2-[(2-methylpropyl)thio]-

Cycloheptatrienylium, (4-methoxyphenyl)-, perchlorate

Carbamic acid, [4-(5-hydroxy-1-pentynyl)phenyl]-, 1,1-dimethylethylester

Butanoic acid, 2-methyl-4-(1H-purin-6-ylamino)-

Butanoic acid, 3-(butylamino)-, methyl ester

Butanoic acid, 3-(phenylthio)-, methyl ester

Cyclohexanamine, N-(3,3,4,4,5,5,6,6,6-nonafluorohexyl)-

1-Pyrrolidinecarboxylic acid,3-[[(cyanomethyl)amino]methylene]-2,4-dioxo-5-(phenylmethyl)-,phenylmethyl ester, (3Z,5S)-

Carbamic acid, [3-hydroxy-3-(4-methylphenyl)propyl]methyl-, phenylester

Benzenemethanol,2-fluoro-6-[[(2-hydroxyethyl)methylamino]methyl]-a-phenyl-

Butanoic acid, 3-amino-, phenylmethyl ester

Butanoic acid, 3-(acetylamino)-3-methyl-

Cyclohexanamine, N,2-dimethyl-, (1R,2R)-rel-

Butanoic acid, 3-(2-hydroxycyclohexylidene)-, ethyl ester, (E)-

Barium, C5-23-branched carboxylate naphthenate octanoate complexes

Butanoic acid, 2-methyl-2-[4-[3-[(methylsulfonyl)oxy]propyl]phenoxy]-,methyl ester, (2R)-

Cyclohexanamine, N,N-dibutyl-2-[(decyloxy)methyl]-, trans-

Butanoic acid, 2-methyl-3-[[2-(trimethylsilyl)phenyl]thio]-, methyl ester,(2S,3S)-

Cyclohexanamine, 4-butyl-4-methoxy-N,N-bis(1-methylethyl)-, trans-

Carbamic acid, [4-[[3-(3-hydroxypropyl)phenyl]methoxy]phenyl]-,1,1-dimethylethyl ester

Cyclohexanamine, N,N-dibutyl-2-[(decyloxy)methyl]-, cis-

Cycloheptanone,5-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2,3-dihydroxy-4-methyl-7-[[tris(1-methylethyl)silyl]oxy]-, (2R,3R,4R,5S,7S)-

180416-55-1 msds

CAS No 180416-55-1 supplier

CASNo 180416-55-1 distributor

CAS # 180416-55-1 manufacturer

CAS Number 180416-55-1 safety

CAS RN 180416-55-1 wholesale

2026-10-12 180416-55-1 N-[3-Chloro-4-(10,11-dihydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-10-ylcarbonyl)phenyl]biphenyl-2-carboxamide